Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized trial of TAK-272 in type 2 diabetes with microalbuminuria
jRCT2080222607Phase 2
- Sponsor
- Takeda
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of imarikiren in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis and Microalbuminuria (6 arms), sponsored by Takeda.
02
Drugs
imarikiren
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosisMicroalbuminuria
Beyond the preview
Go deeper on jRCT2080222607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222607.